Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis
Author(s) -
William E. Plautz,
Vijaya S. Pilli,
Brian C. Cooley,
Rima Chattopadhyay,
Pamela R. Westmark,
Todd M. Getz,
David S. Paul,
Wolfgang Bergmeier,
John P. Sheehan,
Rinku Majumder
Publication year - 2018
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.117.310588
Subject(s) - factor ixa , chemistry , in vivo , fibrin , heparin , platelet , biophysics , plasma protein binding , tissue factor , biochemistry , coagulation , thrombin , factor x , immunology , biology , medicine , microbiology and biotechnology , psychiatry
PS (protein S) is a plasma protein that directly inhibits the coagulation FIXa (factor IXa) in vitro. Because elevated FIXa is associated with increased risk of venous thromboembolism, it is important to establish how PS inhibits FIXa function in vivo. The goal of this study is to confirm direct binding of PS with FIXa in vivo, identify FIXa amino acid residues required for binding PS in vivo, and use an enzymatically active FIXa mutant that is unable to bind PS to measure the significance of PS-FIXa interaction in hemostasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom